Pramodini Medicare Q2 Results 2026 (FY27) statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
Top 10 Healthcare Services companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Pramodini Medicare Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from operations for the half year ended September 30, 2026: Rs. 37.11 crore (Rs. 3,711.31 lakh). EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization):.
From Pramodini Medicare Ltd's Q2 FY27 earnings-call transcript · updated 14 Nov 2026.
How did Pramodini Medicare's revenue grow in the September 2026 quarter?
- Revenue from operations for the half year ended September 30, 2026: Rs. 37.11 crore (Rs. 3,711.31 lakh).
- Revenue from operations for the half year ended September 30, 2025: Rs. 27.75 crore (Rs. 2,774.61 lakh).
- Year-on-year revenue growth: Approximately 33.7% increase from 2025 to 2026 half year.
What happened to Pramodini Medicare's margins in Q2 FY27?
See what Pramodini Medicare Ltd said on profitability & margins — free account, 30 seconds.
What capex is Pramodini Medicare planning?
- Funding of capital expenditure for purchase of medical equipment towards existing and proposed diagnostic centers: Proposed amount Rs. 45.15 Crore; utilized Rs. 14.61 Crore till September 30, 2026; balance Rs. 30.54 Crore remaining.
- IPO net proceeds from fresh issue Rs. 56.03 Crore; out of which Rs. 20.00 Crore utilized by September 30, 2026; Rs. 36.03 Crore balance to be utilized mainly for capex and general corporate purposes.
- General corporate purposes and unidentified inorganic acquisition: Rs. 10.76 Crore proposed; Rs. 5.39 Crore utilized; Rs. 5.36 Crore balance.
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Pramodini Medicare raising money or cutting debt?
See what Pramodini Medicare Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Pramodini Medicare's order book?
See what Pramodini Medicare Ltd said on order book & pipeline — free account, 30 seconds.
More Q2 FY27 results in Healthcare Services
Continue your research
Others in Healthcare Services this season
- Chandan Healthca (Q2 FY27)
Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Unihealth Hosp (Q2 FY27)
1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Pramodini Medicare Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Pramodini Medicare Ltd Q2 FY27 results?
Revenue from operations for the half year ended September 30, 2026: Rs. 37.11 crore (Rs. 3,711.31 lakh). EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization):.
What is Pramodini Medicare Ltd share price analysis?
Pramodini Medicare Ltd currently shows a neutral. The stock trades at a P/E of 13.4 with a market cap of ₹232 Cr. Investors should review the full earnings analysis for detailed insights.
Is Pramodini Medicare Ltd planning capital expenditure?
Funding of capital expenditure for purchase of medical equipment towards existing and proposed diagnostic centers: Proposed amount Rs. 45.15 Crore; utilized Rs. 14.61 Crore till September 30, 2026; ba.
Keep Pramodini Medicare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
